Project Details
Description
A randomized, double-blind, Phase 3 study comparing efficacy and safety of frexalimab (SAR441344) to placebo in adult participants with nonrelapsing secondary progressive multiple sclerosis
| Status | Active |
|---|---|
| Effective start/end date | 11/1/23 → 10/31/28 |
Funding
- SANOFI-AVENTIS US
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.